Douglas RG, Psaltis AJ, Rimmer J, Kuruvilla T, Cervin A, and Kuang Y. Phase 1 clinical study to assess the safety of a novel drug delivery system providing long-term topical steroid therapy for chronic rhinosinusitis International Forum of Allergy & Rhinology, Vol. 9, No. 4, April 2019.

Sharma U, Concagh D, Core L, Kuang Y, You C, Pham Q, Zugates G, Busold R, Webber S, Merlo J, Langer R, Whitesides George M, and Palasis M. The development of bioresorbable composite polymeric implants with high mechanical strength. Nature Materials, 17: 96-103, 2017.


American Rhinologic Society Annual Meeting – September 2020

A novel continuous topical steroid implant (LYR-210) reduces sinonasal type 2 inflammation and rhinologic symptoms in chronic rhinosinusitis

Continuous steroid delivery by LYR-210 improves symptoms of chronic rhinosinusitis

A drug release and pharmacokinetic evaluation of novel mometasone furoate eluting matrices

Back to Top